Latest Breaking News On - Kevinm alexander - Page 1 : comparemela.com

BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting

BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaJean francois tambyKevinm alexanderMargot davisJuliand gillmoreBrettw sperryVikram baliMichel khouriMathew maurerAhmad masriJohn whangNitasha sarswatMazen hannaPablo garcia pavia

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSandeep akkarajuTariq ahmadKevinm alexanderTed koutouzisBiykem bozkurtScientific statement committee members chairAi you canExo irisAddress heartCleared cardiacBusiness wireHeart failureClinical instructorEmergency medicinePulsed wave doppler

CRISPR Gene Editing Takes Next Step in TTR Amyloidosis

A phase 1 study showed robust responses in patients with TTR amyloidosis with cardiomyopathy, similar to those reported last year in amyloid polyneuropathy.

Stanford universityUnited statesUniversity of pennsylvaniaKevinm alexanderKiran musunuruJulian gillmoreUniversity college londonAmerican heart associationYork heart associationNew york heart associationUniversity collegeScientific sessionsIntellia therapeuticsGenomic medicineEdicine genomicClustered regularly interspaced short palindromic repeats